Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
Recruiting now · Early Phase 1
Conditions studied: Dyslipidemias, Obesity
In brief
The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.
Key facts
- Study ID
- NCT05700916
- Run by
- University of Connecticut
- People needed
- 130
- Starts
- 2023-10-20
- Expected to finish
- 2026-06-01
- Last updated by the study team
- 2025-12-22
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- LDL-C ≥ 130 mg/dL
- Waist circumference ≥ 88 cm for women, ≥ 102 cm for men
- Aged 18 to 70 years
You may not qualify if…
- Renal disease
- Liver disease
- Diabetes
- Heart disease
- Stroke
- Cancer
- Eating disorders
- Thyroid disease
- Gut-associated pathologies
- Autoimmune diseases
- Chronic inflammatory diseases
- Scleroderma
- Gallbladder disease
- Blood clotting disorders
- Intravenous drug use
- Fasting plasma/serum triglycerides >500 mg/dL
- Fasting plasma/serum glucose >126 mg/d
- Weight changes >10% over last 4 weeks
- Oral antibiotics use up to 1 month prior to and during study
- Allergy or intolerance to milk products
- Taking lipid-lowering medications (e.g., statins, fibrates)
- Taking anti-inflammatory medications (e.g., corticosteroids)
- Taking medications which primarily affect blood clotting (e.g., warfarin).
Where it is running
- University of Connecticut — Storrs, Connecticut, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.